NCT07642141 Combined Effects of Hypopressive Exercises and Abdominal Bracing on Diastasis Recti Outcomes
| NCT ID | NCT07642141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Diastasis Recti |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-04-02 |
| Primary Completion | 2026-07-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-04-02 with a primary completion date of 2026-07-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diastasis Recti Abdominis (DRA) is the separation of the rectus abdominis muscles along the linea alba, commonly seen after childbirth due to the mechanical and hormonal changes that occur during pregnancy. DRA can negatively affect posture, trunk stability, and breathing patterns, and may result in persistent lumbopelvic pain and weakened core muscles if not properly managed. Although hypopressive exercises and abdominal bracing have individually demonstrated positive effects in reducing inter-recti distance and improving core function, limited research exists regarding their combined effects. This randomized clinical trial aims to evaluate the combined impact of hypopressive exercises and abdominal bracing on inter-recti distance, lumbopelvic pain, and abdominal muscle strength in postpartum women with DRA. The study will include 34 postpartum women recruited from Jinnah Hospital, Lahore, who will be randomly assigned into two groups. Group A will receive both hypopressive exercises and abdominal bracing, while Group B will receive only hypopressive exercises along with standard postpartum physiotherapy. Outcome measures will include pain intensity, lumbopelvic disability, abdominal muscle strength, and inter-recti distance, with data analyzed using SPSS version 25.
Eligibility Criteria
Inclusion Criteria: * Age group of 23 to 30 years * Inter recti distance \> 2 to 5 cm * A women who had undergone a vaginal delivery at least 8 weeks before the first measurement * A postpartum female with the presence of diastasis rectus abdominis * BMI under or equal to 29kg/m2 Exclusion Criteria: * Pregnant females (29) * Subjects who underwent any recent abdominal surgeries * Patient diagnosed with a Fibroid uterus * Patient diagnosed with abdominal hernia * Cesarean section (C-section) * Chronic medical conditions such as diabetes, uncontrolled hypertension, cardiovascular disease, or thyroid disorders.
Contact & Investigator
Muzzammil Akhtar
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07642141 clinical trial?
This trial is open to female participants only, aged 23 Years or older, up to 30 Years, studying Diastasis Recti. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642141 currently recruiting?
Yes, NCT07642141 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07642141 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07642141 clinical trial?
NCT07642141 is sponsored by Riphah International University. The principal investigator is Muzzammil Akhtar at Riphah International University. The trial plans to enroll 34 participants.